Global Oxidative Stress Assay Market Segmentation, By Product (Consumables, Instruments, Services), Test Type (Indirect Assays, Antioxidant Capacity Assays, Enzyme-based Assays, Reactive Oxygen Species (ROS)-based Assays), Disease Type (Cardiovascular Disease, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Cancer, Asthma), Technology (Enzyme-linked Immunosorbent Assay (ELISA), Chromatography, Flow Cytometry, Microscopy, High-Content Screening, Label-free Detection Technology), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations) – Industry Trends and Forecast to 2031
Oxidative Stress Assay Market Analysis
Oxidative stress, the conflict between the production of reactive oxygen species (ROS) and a cell's cancer-prevention agent defences, is linked to human illnesses, just as maturation is. This item bundle includes bioluminescence-based oxidative stress assays for identifying glutathione, detecting changes in ROS, and estimating the proportion of reduced to oxidised glutathione as markers of cell health. Oxidative stress assays are commonly used in cell cultures used for biopharmaceutical production. As a result, biopharmaceutical and equipment companies are the largest end users of oxidative stress assays.
Oxidative Stress Assay Market Size
Global oxidative stress assay market size was valued at USD 0.93 billion in 2023 and is projected to reach USD 2.15 billion by 2031, with a CAGR of 11.10% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Oxidative Stress Assay Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe) Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US)
|
|
Market Opportunities
|
|
Oxidative Stress Assay Market Definition
Oxidative stress assays are used to identify and screen the levels of oxidative stress markers and reagents in cells. The tests detect oxidative stress in general, glutathione levels, fluorescent protein-based redox sensors, reactive oxygen species (ROS), and lipid peroxidation.
Oxidative Stress Assay Market Dynamics
Drivers
- The Rapid Antigen Testing Promotes Market Growth
The availability of technologically advanced equipment with efficient technologies to achieve high efficiency and precision in oxidative stress testing is one of the major factors driving the growth and demand for oxidative stress assay market.
- Significant Collaborations among Key Market Players
rapid technological advancements such as high-content screening for drug discovery and rising government funding for life science research are driving growth in the global market from 2021 to 2028.
Regulatory Compliance
Maintaining compliance with medical reforms and diagnostics raises the demand for these solutions.
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the oxidative stress assay market.
Opportunities
The strong trend of R&D investments in the biotechnology and pharmaceutical industries is also boosting market growth. Furthermore, rising per capita disposable income is one of the key factors fueling the growth of the oxidative stress assay market.
Restraints/Challenges
The high cost of instruments and a lack of trained manpower for new and emerging technologies will limit the growth of the oxidative stress assay market, while a lack of awareness among the population may pose a challenge to the market's growth.
This oxidative stress assay market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oxidative stress assay market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Oxidative Stress Assay Market
Due to the impact on research and manufacturing activities worldwide, COVID-19 is expected to have a low-to-moderate impact on the oxidative stress assays market. COVID-19 had a negative economic impact on businesses and financial markets. Several industries have been impacted by stock market volatility and slowing global growth during the pandemic. Due to strict government regulations, supply chain disruptions, and low R&D activities, the market for oxidative stress assays has experienced a slight downturn. However, with the acceleration of academic research and other commercial activities, the market is expected to grow in the coming years.
Oxidative Stress Assay Market Scope
The oxidative stress assay market is segmented on the basis of product type, test type, disease type, technology and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product type
- Consumables
- Instruments
- Services
On the basis of product type, the global oxidative stress assay market is segmented into consumables, instruments and services. Consumables have further been segmented into kits and reagents.
Test type
- Indirect assays
- Antioxidant capacity assays
- Enzyme-based assays
- Reactive oxygen species (ROS)-based assays
Based on test type, the oxidative stress assay market is segmented into indirect assays, antioxidant capacity assays, enzyme-based assays and reactive oxygen species (ROS)-based assays. Indirect assays have further been segmented into protein-based assays, lipid-based assays and nucleic acid-based assays. Antioxidant capacity assays have further been segmented into glutathione assays, ascorbic acid assays and cell-based exogenous antioxidant assays.
Disease type
- Cardiovascular disease
- Diabetes
- Chronic obstructive pulmonary disease (copd)
- Cancer
- Asthma
The global oxidative stress assay market is segmented on the basis of disease types into cardiovascular disease, diabetes, chronic obstructive pulmonary disease (COPD), cancer and asthma.
Technology
Enzyme-linked immunosorbent assay (ELISA)
- Chromatography
- Flow cytometry
- microscopy
- High-content screening
- Label-free detection technology
On the basis of technology, the oxidative stress assay market is segmented into enzyme-linked immunosorbent assay (ELISA), chromatography, flow cytometry, microscopy, high-content screening and label-free detection technology.
End User
- Pharma and biotech companies
- Academic research institute
- Clinical laboratories
- Contract research organoizations
- Others
The end user segment of oxidative stress assay market is segmented into pharmaceutical and biotechnology companies, academic research institutes, clinical laboratories and contract research organizations.
Oxidative Stress Assay Market Regional Analysis
The oxidative stress assay market is analysed and market size insights and trends are provided by country, product type, test type, disease type, technology and end useras referenced above.
The countries covered in the oxidative stress assay market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The North America region leads the oxidative stress assay market due to the region's growing elderly population, rising public awareness, and innovative technologies. Because of growing government initiatives, increased awareness, and high investment in this region's healthcare sector, Asia-Pacific is expected to expand at a significant rate from 2021 to 2028.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The oxidative stress assay market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oxidative stress assay market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oxidative stress assay market. The data is available for historic period 2010-2020.
Oxidative Stress Assay Market Share
The oxidative stress assay market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oxidative stress assay market.
Oxidative Stress Assay Market Leaders Operating in the Market Are:
- Abcam, plc (UK)
- Enzo Biochem, Inc. (US)
- Merck KGaA (Germany)
- QIAGEN N.V. (Netherlands)
- Thermo Fisher Scientific, Inc. (US)
- AMS Biotechnology (Europe) Ltd. (UK)
- BioVision, Inc. (US)
- Cell Biolabs, Inc. (US)
- Oxford Biomedical Research (US)
- Promega Corporation (US)
- Cayman Chemical (US)
- Eagle Biosciences, Inc. (US)
- Arbor Assays (US)
- Hycult Biotech (Netherlands)
- Callegari SRL (Italy)
- Kamiya Biomedical Company (US)
Latest Developments in Oxidative Stress Assay Market
- Abcam plc (UK) acquired Expedeon's (Germany) Proteomics and Immunology business in 2020 to improve its conjugation capability.
- In 2018, Abcam plc (UK) signed a strategic MoU collaboration agreement with QIAGEN (Suzhou) to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market.
- BioVision, Inc. (US) introduced the nitrite Assay Kit in 2018. (Griess Reagent)
- Cayman Chemical (US) began construction on a USD 20 million research and development facility at its headquarters in the United States in 2020.
SKU-